Merck Says Data Shows Cognigram as Sensitive Assessment

Results from two new studies add to the body of evidence that supports Cognigram(TM) as a sensitive assessment to detect and monitor cognitive decline over time, namely in healthy individuals and adults with mild cognitive impairment (MCI) that are carriers of a biological marker in the brain - Aβ amyloid.(1,2) Data from two studies were